K1709

Thermo Scientific™ GeneBLAzer™ D1-CRE-blaCHO-K1 Cells

Manufacturer: Thermo Scientific™

Select a Size

Pack Size SKU Availability Price
Each of 1 K1709-Each-of-1 In Stock ₹ 9,05,224.80

K1709 - Each of 1

₹ 9,05,224.80

In Stock

Quantity

1

Base Price: ₹ 9,05,224.80

GST (18%): ₹ 1,62,940.464

Total Price: ₹ 10,68,165.264

Assay Entry

Cell-based beta lactamase reporter gene

Content And Storage

LiveBLAzer™-FRET B/G Loading Kit, Solution D and other materials are required separately; please refer to the protocol.Includes:• GeneBLAzer™ D1-CRE-blaCHO-K1 cells• GeneBLAzer™ D1-CRE-blaCHO-K1 Assay Protocol• Certificate of AnalysisThe GeneBLAzer™ D1-CRE-blaCHO-K1 cells are shipped on dry ice and should be stored in liquid nitrogen immediately upon receipt.

For Use With (Application)

FRET

Product Line

GeneBLAzer™

Reporter Gene

BLA (Beta-Lactamase)

Type

CHO-K1 Cells

System Type

GeneBLAzer™

Cell State

Dividing Cells

Detection Method

Fluorescence

Gene Symbol

DRD1

Quantity

2 x 106Cells

Target Entry

DRD1, D1

Cell Line

CHO-K1

Druggable Target

GPCR

Related Products

Img

Thermo Scientific™

K1553

--

Img

Thermo Scientific™

K1472

--

Img

Thermo Scientific™

K1733

--

Img

Thermo Scientific™

K1732

--

Img

Thermo Scientific™

K1718

--

Img

Thermo Scientific™

K1735

--

Img

Thermo Scientific™

K1784

--

Img

Thermo Scientific™

K1716

--

Description

  • GeneBLAzer™ D1-CRE- bla CHO-K1 cells contain the human Dopamine Receptor 1 (D1) stably integrated into the CellSensor™ CRE- bla CHO-K1 cell line
  • CellSensor™ CRE- bla CHO-K1 cells (Cat
  • No
  • K1535) contain a beta-lactamase reporter gene under control of the Cyclic AMP Response Element (CRE) response element
  • The GeneBLAzer™ D1-CRE- bla CHO-K1cells are functionally validated for Z' and EC 50 concentrations of dihydrexidine
  • In addition, GeneBLAzer™ D1-CRE- bla CHO-K1 DA cells have been tested for assay performance under variable conditions
  • These data are found in the Validation & Assay Performance Summary
  • Agonists and antagonists of dopamine D1 receptors are in various stages of clinical trials for the treatment of neurological disorders like Parkinson's disease, Alzheimer's disease, schizophrenia, and psychosis
  • For Academic pricing please login or contact us at discoverysciences@invitrogen.com.